SCHEMBL7744080

SCHEMBL7744080

CC1CC(=O)C(Cc2ccccc2)(C(=O)O)O1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
NR3C2 P08235 8/20 0.37
TSHR P16473 1/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD11B1 P28845 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386587 0.71 AKR1C1 (0.36) HSD11B1ITGB1ITGA4ITGB7LMNA
SCHEMBL14159710 0.69 TSHR (0.43) CYP3A4TSHRLMNACYP2D6CYP2C19
SCHEMBL14159720 0.69 GAA (0.38) CYP3A4TSHRMEN1KMT2ALMNA
SCHEMBL1841591 0.66 LMNA (0.46) CYP3A4MAPTMEN1KMT2AHSD11B1
SCHEMBL7380005 0.65 ITGB1 (0.39) ITGB1ITGA4ITGB7LMNACYP2C19
SCHEMBL2391023 0.65 CYP3A4 (0.41) CYP3A4TSHRMAPTMEN1KMT2A
SCHEMBL4701574 0.63 MAOA (0.33) CYP3A4TSHRMEN1KMT2ALMNA
SCHEMBL576343 0.63 LMNA (0.41) LMNA
SCHEMBL27989707 0.62 MAOA (0.40) CYP3A4LMNA
SCHEMBL13818225 0.62 LMNA (0.43) CYP3A4KMT2AHSD11B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed